MarilynKGlassbergMD

PubMed

• Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial.
  Steven D Nathan, Natasa Rajicic, Rosemarie Dudenhofer, Rahat Hussain, Rahul Argula
  Annals of the American Thoracic Society. 2024-12-01
• Efficacy and Safety of Admilparant, an LPAAntagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial.
  Tamera J Corte, Juergen Behr, Vincent Cottin, Marilyn K Glassberg, Michael Kreuter
  American Journal of Respiratory and Critical Care Medicine. 2024-10-11
• 2 citations
  Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.
  Ayodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, Timothy S Blackwell, Tamera J Corte
  American Journal of Respiratory and Critical Care Medicine. 2024-08-15

Journal Articles

• Sensitivity Analyses of the Change in Forced Vital Capacity in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis  
  Lederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE Jr, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW, Chest, 1/9/2015
• Pulmonary Complications of Inflammatory Myopathy  
  Miller SA, Glassberg MK, Ascherman DP, Rheum Dis Clin North Am, 1/1/2015
• A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis  
  King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sa..., N Engl J Med, 1/29/2014
• A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease  
  Doyle TJ, Lee JS, Dellaripa PF, Lederer JA, Matteson EL, Fischer A, Ascherman DP, Glassberg MK, Ryu JH, Danoff SK, Brown KK, Collard HR, Rosas IO, Chest, 1/1/2014
• 17Beta-estradiol replacement reverses age-related lung disease in estrogen-deficient C57BL/6J mice  
  Glassberg MK, Choi R, Manzoli V, Shahzeidi S, Rauschkolb P, Voswinckel R, Aliniazee M, Xia X, Elliot SJ, Endocrinology, 1/1/2014
• Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach  
  Glassberg MK, Hare JM, Toonkel RL, Matthay MA, Am J Respir Crit Care Med, 1/15/2013
• Mesenchymal stem cells and idiopathic pulmonary fibrosis Potential for clinical testing  
  Toonkel RL, Hare JM, Matthay MA, Glassberg MK, Am J Respir Crit Care Med, 1/15/2013
• To be or not to be a neoplasm: what is lymphangioleiomyomatosis? Are we calling it what it really is?  
  Glassberg MK, Am J Respir Crit Care Med, 1/1/2013
• Improving clinical trial efficiency in Idiopathic Pulmonary Fibrosis: Multivariate Analysis to Support the design of the ASCEND study  
  Noble PW, Bradford, WZ, Fagan EA, Glaspole I, Glassberg MK, Lancaster L, Kardarzke D, Lederer D, Leff, JA, Nathan SD, Pereira C, Sahn SA, Swigris JJ, and King TE, Am J Resp Crit Care Med, 1/1/2013
• The influence of Hispanic ethnicity on non-small cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results (SEER) dat...  
  Saeed AM, Toonkel R, Glassberg MK, Ngyuen D, Hu JJ, Zimmers TA, Robbins DJ, Koniaris LG, and Lally BE, Cancer, 1/15/2012
• Pirfenidone in patient with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials  
  Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, duBois RM, for the CAPACITY Study Group, Lancet, 1/21/2011
• 17Beta -estradiol modifies diabetic wound healing by decreasing MMP activity  
  Pincus DJ, Kassira N, Gombosh M, Berho M, Glassberg MK, Karl M, Elliot SJ, and Thaller S, Wounds, 1/1/2010
• Estrogen deficiency and tobacco smoke exposure promote matrix metalloproteinase-13 activation in skin of aging B6 mice  
  Kassira N, Glassberg MK, Jones C, Pincus DJ, Elliot SJ, Fritz JR, Karl M, Thaller S., Lancet, Ann Plast Surg, 1/1/2009
• Estrogen deficiency and tobacco smoke promote MMP-13 activation in skin of aging B6 mice  
  Kassira N, Glassberg MK, Jones C, Pincus DJ, Elliot SJ, Fritz JR, Karl M, Thaller S, Ann Plast Surg, 1/1/2009
• Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via MMP-induced cell invasiveness  
  Glassberg MK, Elliot SJ, Fritz J, Catanuto P, Potier M, Donahue R, Stetler-Stevenson W, Karl M, J Clin Endocrinol Metab, 1/1/2008
• Improving early recognition of idiopathic pulmonary fibrosis  
  Glassberg MK, Pulmonary Perspectives in Chest, 1/1/2004
• Benign metastasizing leiomyoma and lymphangioleiomyomatosis: sex-specific diseases?  
  Pitts S, Oberstein EM, Glassberg MK, Clinics in Chest Medicine, 1/1/2004
• Lymphangioleiomyomatosis  
  Glassberg MK, Clinics in Chest Medicine, 1/1/2004
• Lymphangioleiomyomatosis and SZ alpha (1)-antitrypsin disease: a unique combination?  
  Chan AL, Kwack S, Jones KD, Glassberg MK, Gherman CR, Chest, 1/1/2003
• Como reconocer y tratar la linfangioleiomiomatosis?  
  Oberstein EM, Gomez JP, and Glassberg MK, Med Clin (Barc), 1/28/2002
• Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)  
  Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, Walker CL, Noonan D, Kwiatkowski DJ, Chou MM, Panettieri RA Jr, Krymskaya VP, J Biol Chem, 1/23/2002
• Pulmonary complications in pregnancy, part II: Emboli and other diseases in pregnancy  
  Oberstein EM, Marder A, Pitts S, Glassberg MK, J Resp Dis, 1/1/2002
• Pulmonary complications of pregnancy, part I: Infection and asthma  
  Oberstein EM, Marder A, Pitts S, and Glassberg MK, J Resp Dis, 1/1/2002
• Recognizing Lymphangioleiomyomatosis  
  Glassberg MK, Oberstein E, Women's Health in Primary Care, 1/1/2001
• A transformed murine Leydig cel line expresses the ETA receptor subtype  
  Ergul A, Glassberg MK, Freeman ME, Puett D, Mol Cell Biochem, 1/13/1994
• Join now to see all

Books/Book Chapters

• Principles of Gender-Specific Medicine 
  Chapter: Rare disease in women; BML and LAM. 
  Glassberg MK, Aliniazee MEditors: Marianne Legato.Edition 2nd,2009
• Principles of Gender-Specific Medicine 
  Glassberg MKEditors: Marianne Legato (Glassberg MK, Pulmonary Section Editor).Edition 2nd,2009
• Principles of Gender-Specific Medicine 
  Chapter: The spectrum of interstitial lung disease in patients with collagen vascular disease 
  Glassberg MK, Aliniazee MEditors: Marianne Legato.Edition 2nd,2009
• Clinics in Chest Medicine 
  Chapter: Sex, Gender, and Respiratory Health and Disease. 
  Glassberg MK, Murin S, Weisman IElsevier Science W.B. Saunders, Philadelphia, PA2004
• Clinics in Chest Medicine 
  Chapter: Benign Metastasizing Leiomyoma and Lymphangioleiomyomatosis: sex-specific diseases? 
  Pitts S, Oberstein EM, Glassberg MKElsevier Science W.B. Saunders, Philadelphia, PA2004
• Clinics in Chest Medicine 
  Chapter: Lymphangioleiomyomatosis. 
  Glassberg MKElsevier Science W.B. Saunders, Philadelphia, PA2004
• Encyclopedia of Women's Health 
  Chapter: Asthma. 
  Glassberg MK, Oberstein EKluwer Academic, New York, NY2004
• Encyclopedia of Women's Health 
  Chapter: Chronic Obstructive Pulmonary Disease. 
  Glassberg MK, Franco SKluwer Academic, New York, NY2004
• Encyclopedia of Women's Health 
  Chapter: Lung Transplantation. 
  Glassberg MK, Lange RKluwer Academic, New York, NY2004
• Encyclopedia of Women's Health 
  Chapter: Lung Cancer. 
  Franco S, Glassberg MKKluwer Academic, New York, NY2004
• Encyclopedia of Women's Health 
  Chapter: Lung Diseases in Pregnancy. 
  Glassberg MK, Oberstein EKluwer Academic, New York, NY2004
• Tuberculosis and Its Clinical Management 
  Glassberg MK, Cameron CCHome Educators, Inc.1997
• Update on Tuberculosis 
  Glassberg MKEditors: Cameron C..Home Educators, Inc.1995
• Tuberculosis: Disease Of The 90's 
  Glassberg MKEditors: Cameron C..Home Educators, Inc.1993
• Endothelium Derived Relaxing Ractors 
  Chapter: Signal transduction pathways in endothelial cells. 
  Page 6 - 116Ryan US, Glassberg MK, Johns AEditors: Rubanyi GM, VanHoutte PM.Karger B1990
• Join now to see all

Abstracts/Posters

• Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.
  Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G., Glassberg MK, et al, N Engl J Med, Idiopathic Pulmonary Fibrosis Clinical Research Network, 1/29/2014
• Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical tr...
  Saketoo LA, Mittoo S, Huscher D, Khanna D, Deallaripa PF, Distler O, Flasherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Boelecka OM, Glassberg MK, et al, Thorax, 1/28/2014
• Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
  Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Glassberg MK, et al, Ann Intern Med, 1/7/2013
• Six-minute walk test in IPF.
  du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr., Glassberg MK, e..., Am J Respir Crit Care Med, 1/1/2011
• Doxycycline reverses 17Beta-estradiol mediated effects on estrogen receptor alpha and Beta via P13K Pathway in LAM.
  Glassberg MK, Manzoli V, Elliot SJ, American Thoracic Society International Conference, 1/1/2011
• Age Related Oxidant Injury is Accelerated by Estrogen Deficiency in the Lung of C57Bl6 mice.
  Glassberg MK, Manzoli V, Vlassara H, Striker GE, Elliot SJ, Office of Research on Women's Health 20th Anniversary, 1/28/2010
• Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
  Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR; Imatinib-IPF Study, m J Respir Crit Care Med, 1/15/2010
• Age related Oxidant Injury Is Accelerated by Estrogen Deficiency.
  Glassberg MK, Society International Conference, 1/1/2010
• Effect of interferon gamma-1b on Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo...
  King TE Jr., Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Glassberg MK, et al, Lancet, 1/18/2009
• Estrogens in Pulmonary Lymphangioleiomyomatosis: a role for Doxycycline.
  Glassberg MK, Catanuto P, Fritz J, Elliot SJ, Women's Health Day, University of Miami Miller School of Medicine, 1/1/2008
• Estrogen Receptor Activation Contributes to the Progression of Pulmonary Lymphangioleiomyomatosis via Matrix Metalloproteinase-induced Cell Invasiveness.
  Glassberg MK, Elliot SJ, Fritz J, Potier M, Karl M, Endocrine Society, 1/1/2007
• Estrogen modulates cigarette smoke-induced lung injury in female C57BL6 mice.
  Glassberg MK, Fritz J, Lilo S, Frank L, Karl M, and Elliot SJ, Am J Resp Crit Care Med, 1/1/2007
• Estrogens and Matrix metalloproteinases in LAM.
  Glassberg MK,Poitier M, Elliot SE, Karl M, Am J Resp Crit Care Med, 1/1/2006
• Doxycycline improves exercise capacity in patients with LAM.
  Glassberg MK, Fritz J, Karl M, Elliot SE, LAMposium, 1/1/2006
• TGF-Beta controls CTGF effects on MMP-2 and TIMP-2 activity on ovine lung myofibroblasts.
  Parades P, Elliot SE, Glassberg MK, Am J Resp Crit Care Med, 1/1/2005
• Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis.
  Strieter RM, Starko KM, Enelow RI, Noth I, Valentine VG and members of the Idiopathic Fibrosis Biomarkers Study Group (Glassberg MK), Am J Respir Crit Care Med, 1/15/2004
• A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
  Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr; Idiopathic Pulmonary Fibrosis Study Group (Glassberg MK), N Engl J Med, 1/1/2004
• TGF-Beta controls CTGF effects on MMP-2 and MMP-9 activity on ovine lung myofibroblasts.
  Glassberg MK, Lilo S, Parades P, Li H, Scuri M, Duncan M, Am J Resp Crit Care Med, 1/1/2004
• Randomized, Double-Blind, Placebo-controlled study of interferon gamma-1b treatment on biomarkers of fibrosis, angiogenesis, and antimicrobial activity in patients wit...
  Strieter R, Enelow R, Noth I, Valentine V, Brown K, Glassberg, MK, et al, Am J Resp Crit Care Med, 1/1/2003
• LAM: A living cohort and their demographics.
  Oberstein E, Fleming L, Glassberg MK, LAMposium 2001, Cincinnati, OH, 1/1/2001
• Epidemiologic study of 83 women with LAM.
  Oberstein E, Fleming L, Glassberg MK, Am J Resp Crit Care Med, 1/1/2001
• . Investigation of the TSC2 locus in LAM.
  Li H, Basterrechea HR, Baumbach-Reardon LL, Glassberg MK, American Society of Human Genetics, San Francisco, CA, 1/17/1999
• A role for growth factors in LAM.
  Glassberg MK, Flaherty DM, He L, Chest, 1/1/1999
• PDGF in LAM.
  Styblo JL, Flaherty D, Li H, Glassberg MK, Am J Resp Crit Care Med, 1/1/1999
• The proliferative cell in LAM is a myofibroblast.
  Glassberg MK, Styblo JL, Alexis J, Am J Resp Crit Care Med, 1/1/1999
• Join now to see all

Lectures

• "Idiopathic Pulmonary Fibrosis: Raising the Index of Suspicion in Primary Care" 
  Princeton , NJ - 1/30/2015
• "Stem Cell Therapy in Interstitial Lung Disease" 
  Miami Beach, FL - 1/23/2015
• "Pulmonary Fibrosis Management Strategies" 
  Washington, DC - 1/13/2015
• "A new era in IPF: using cell-based therapies in chronic lung disease" 
  Palm Beach, FL - 1/13/2015
• "The scope of lung disease in Rheumatoid Arthritis" 
  St. Luke's Hospital, St Louis, MO - 1/12/2015
• "Managing IPF in 2015" 
  Piedmont Hospital, Atlanta, GA - 1/10/2015
• "A New Era in IPF: moving into cell-based therapies" 
  New York, NY - 1/9/2015
• "Applying new options for patients with IPF" 
  Atlanta, GA - 1/7/2015
• "Understanding IPF in 2015?" 
  Fort Lauderdale, FL - 1/6/2015
• "Navigating the new era in IPF: Collaborative Patient Care" 
  Miami, FL - 1/1/2015
• "Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis; safety first" 
  Milton Hershey Medical Center - 1/17/2014
• ""Two new drugs: new choices for the treatment of IPF" 
  Sea World - 1/13/2014
• "Five Consecutive Cases of Open Lung Biopsy that Led to an Improvement in Outcome" 
  1/13/2014
• "A New Era in IPF" 
  Wayne State University - 1/10/2014
• "Approaching stem cells as a therapy for lung disease: safety first" 
  University of Louisville - 1/7/2014
• "Living with IPF-a New Era" 
  Miami, FL - 1/1/2014
• "First in Man pulmonary clinical trials" 
  1/30/2013
• "IPF: To be or not to be" 
  University of Miami Miller School of Medicine - 1/29/2013
• "New directions in IPF: a role for MSCs?" 
  Baylor College of Medicine - 1/25/2013
• "Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis; Potential for Clinical Testing." 
  Mount Sinai School of Medicine - 1/22/2013
• "A role for stem cells in lung disease: are we catching up to the cardiologists?" 
  Beth Israel Hospital - 1/20/2013
• "IPF: Current clinical conundrums" 
  Chicago, IL - 1/18/2013
• "IPF Update" 
  Delaware County Hospital, Delaware, PA - 1/1/2013
• "IPF: A Clinical Conundrum" 
  Brown University School of Medicine, Rhode Island Hospital, Providence, RI - 1/17/2012
• "Common elements in uncommon chronic lung diseases" 
  Orlando, FL - 1/16/2012
• Join now to see all

Other

• Proactive and comprehensive management of patients with IPF. 
  Glassberg MK, Rosen G, Staton G
  https://www.ipfrally.com/managing-the-ipf-patient
  1/1/2014
• Targeting the Pathophysiology of Idiopathic Pulmonary Fibrosis: Inhibiting Fibrogenetic Processes. 
  Glassberg MK
  http://www.quintilesmeded.com/inhibitingIPF
  1/1/2013
• Current and Investigational Treatment Options for IPF. 
  Glassberg MK, Point of Care360: Idiopathic Pulmonary Fibrosis Edition
  http://www.Projectknowledge.com
  1/1/2013
• Improving Clinical Trial Efficiency in Idiopathic Pulmonary Fibrosis (IPF): Multivariate Analysis to Support the Design of the ASCEND Study. 
  Noble PW, Bradford WZ, Glaspole I, Glassberg MK, Lancaster L, Lederer D, Nathan SD,Pereira CA, Sahn SA, Swigris JJ, King TE
  1/1/2013
• Prevention Of Advanced Glycosylated Endproduct-Related Oxidant Injury With Pyridoxamine And Estrogen Regulates ER in the Lungs of Aging C57Bl6 Mice. 
  Choi R, Elliot SJ, Shahzeidi S, Glassberg MK
  1/1/2013
• Join now to see all